Home › Funds › Lynx1 Capital Management LP › NUVB

Lynx1 Capital Management LP position in NUVB

NUVATION BIO INC · Health Care

Lynx1 Capital Management LP reported holding 16,029 shares of NUVB (NUVATION BIO INC) in its Q3 2026 13F filing — a position valued at US$90K, representing 0.01% of its reported portfolio and ranking #30 among its reported holdings. Lynx1 Capital Management LP has disclosed NUVB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)16.03K sh
Reported value held$89.76K
Portfolio Weight0.01%
First reportedQ2 2026
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Lynx1 Capital Management LP's NUVB position evolved

Lynx1 Capital Management LP first disclosed a stake in NUVB in Q2 2026 at 16,029 shares (US$91K). Across 2 filings, Lynx1 Capital Management LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 16,029 shares valued at US$90K.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 16.03K $91.05K New
Q3 2026 16.03K $89.76K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NUVB and 13F data

NUVB (NUVATION BIO INC) is a Health Care company. 56 other funds we track also report a position in NUVB — the largest reported positions include Decheng Capital LLC (US$145.3M), Context Capital Management, LLC (US$53.1M), Laurion Capital Management LP (US$43.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NUVB

All NUVB fund holders →

FAQ

How long has Lynx1 Capital Management LP held NUVB?

Lynx1 Capital Management LP has disclosed NUVB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Lynx1 Capital Management LP's current position in NUVB?

As of Q3 2026, Lynx1 Capital Management LP holds 16.03K shares of NUVB (NUVATION BIO INC), valued at $89.76K, representing 0.01% of its reported portfolio and ranking #30.

Has Lynx1 Capital Management LP been buying or selling NUVB?

In the latest 13F filing (Q3 2026), Lynx1 Capital Management LP held unchanged its position in NUVB.

Which other funds hold NUVB?

Other major institutional holders of NUVB include Decheng Capital LLC, Context Capital Management, LLC, Laurion Capital Management LP, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.